ScholarIQanswers from OpenAlex

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib

PaperCitations, authors & open-access status

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib have?

ScholarIQcitation count

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib has 12 citations in the OpenAlex counts ScholarIQ stores.

When was Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib published?

ScholarIQyear

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib has 2024 year in the ScholarIQ index.

What is the open-access status of Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib?

ScholarIQoa status

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib has closed oa status in the ScholarIQ index.

What is the DOI of Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib?

ScholarIQdoi

The DOI for Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib is on the source record.

What is the PMID of Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib?

ScholarIQpmid

The PMID for Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib is on the source record.

What is the OpenAlex record for Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib?

ScholarIQopenalex

The OpenAlex for Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial